Travere Therapeutics Inc’s recent filing unveils that its CHIEF MEDICAL OFFICER Inrig Jula unloaded Company’s shares for reported $11940.0 on Jul 01 ’25. In the deal valued at $14.65 per share,815 shares were sold. As a result of this transaction, Inrig Jula now holds 88,787 shares worth roughly $1.33 million.
Then, Cline Christopher R. sold 1,784 shares, generating $37,553 in total proceeds. Upon selling the shares at $21.05, the CHIEF FINANCIAL OFFICER now owns 93,126 shares.
Before that, Dube Eric M sold 18,924 shares. Travere Therapeutics Inc shares valued at $398,350 were divested by the CHIEF EXECUTIVE OFFICER at a price of $21.05 per share. As a result of the transaction, Dube Eric M now holds 419,173 shares, worth roughly $6.29 million.
A number of analysts have revised their coverage, including Citigroup’s analysts, who remained covering the stock and in mid June has reiterated a ‘”a Buy”‘ rating for it. Cantor Fitzgerald began covering TVTX with “an Overweight” recommendation on January 10, 2025. Wells Fargo revised its rating on October 21, 2024. It rated TVTX as “an Overweight” which previously was an “an Equal weight”.
Price Performance Review of TVTX
On Thursday, Travere Therapeutics Inc [NASDAQ:TVTX] saw its stock jump 1.15% to $15.01. Over the last five days, the stock has lost -0.79%. Travere Therapeutics Inc shares have risen nearly 81.28% since the year began. Nevertheless, the stocks have fallen -13.83% over the past one year. While a 52-week high of $25.29 was reached on 02/11/25, a 52-week low of $7.72 was recorded on 04/09/25.
Levels Of Support And Resistance For TVTX Stock
The 24-hour chart illustrates a support level at 14.87, which if violated will result in even more drops to 14.73. On the upside, there is a resistance level at 15.12. A further resistance level may holdings at 15.23.
How much short interest is there in Travere Therapeutics Inc?
A steep rise in short interest was recorded in Travere Therapeutics Inc stocks on 2025-06-13, dropping by -0.11 million shares to a total of 10.33 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 10.43 million shares. There was a decline of -1.02%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on October 16, 2024 when Scotiabank began covering the stock and recommended ‘”a Sector outperform”‘ rating .
